Anatürk M, Patel R, Ebmeier KP, et al. Development and validation of a dementia risk score in the UK Biobank and Whitehall II cohorts. BMJ Ment Health 2023; 26:e300719.

Blackman G, Neri G, Al-Doori O, et al. Prevalence of neuroradiological abnormalities in first-episode psychosis: A systematic review and meta-analysis. JAMA Psychiatry 2023; 80:1047-1054.

Crowe M, Manuel J, Carlyle D, et al. The experience of ‘treatment‐resistant’ depression: A qualitative meta‐synthesis. International Journal of Mental Health Nursing 2023b; 32(3), 662-672. 

D’Adamo L, Ghaderi A, Rohde P, et al. Evaluating whether a peer-led dissonance-based eating disorder prevention program prevents onset of each eating disorder type. Psychological Medicine 2023; 1–8.

Davies MR, Glen K, Mundy J, et al. (2023). Factors associated with anxiety disorder comorbidity. Journal of Affective Disorders 2023; 323, 280-291.  

Degenhardt L, Clark B, Macpherson G, et al. Buprenorphine versus methadone for the treatment of opioid dependence: a systematic review and meta-analysis of randomised and observational studies. The Lancet Psychiatry 2023.

Hansen HG, Starzer M, Nilsson SF, et al. Clinical Recovery and Long-Term Association of Specialized Early Intervention Services vs Treatment as Usual Among Individuals With First-Episode Schizophrenia Spectrum Disorder: 20-Year Follow-up of the OPUS Trial. JAMA Psychiatry.2023;80(4):371–379. doi:10.1001/jamapsychiatry.2022.5164  

Heissel A, Heinen D, Brokmeier LL, et al. Exercise as medicine for depressive symptoms? A systematic review and meta-analysis with meta-regression. British Journal of Sports Medicine 2023.

Haw R, Hartley S, Trelfa S, et al. A systematic review and meta‐ethnography to explore people’s experiences of psychotherapy for self‐harm. British journal of clinical psychology 2023; 62(2), 392-410.  

Hull TD, Malgaroli M, Gazzaley A, et al. At-home, sublingual ketamine telehealth is a safe and effective treatment for moderate to severe anxiety and depression: findings from a large, prospective, open-label effectiveness trial. Journal of Affective Disorders 2022; 314, 59-67.

Jack RH, Joseph RM, Hollis C, et al. Seasonal trends in antidepressant prescribing, depression, anxiety and self-harm in adolescents and young adults: an open cohort study using English primary care data. BMJ Ment Health 2023; 26:e300855.  

NICE. 2023. Bipolar disorder: assessment and management. Clinical guideline [CG185] Published: 24 September 2014. Last updated: 21 December 2023.

NICE. 2023. Flow transcranial direct current stimulation for treating depression.

Medtech innovation briefing [MIB324 ]Published: 08 November 2023. 

Nordby ES, Guribye F, Nordgreen T, et al. Silver linings of ADHD: a thematic analysis of adults’ positive experiences with living with ADHD. BMJ Open 2023; 13:e072052. doi: 10.1136/bmjopen-2023-072052  

Papola D, Ostuzzi G, Tedeschi F, et al. CBT treatment delivery formats for panic disorder: a systematic review and network meta-analysis of randomised controlled trials. Psychological Medicine 2023; 1-11.

Pizzol D, Trott M, Butler L, et al. Relationship between severe mental illness and physical multimorbidity: a meta-analysis and call for action. BMJ Ment Health 2023; 26:e300870.  

Sahker E, Furukawa TA, Luo Y, et al. Estimating the smallest worthwhile difference of antidepressants: a cross-sectional survey. BMJ Ment Health 2024; 27:e300919.

Town R, Hayes D, March A, et al. Self‑management, self‑care, and self‑help in adolescents with emotional problems: a scoping review. European Child & Adolescent Psychiatry 2023.  

Wu T, Xiao X, Yan S, et al. Digital health interventions to improve adherence to oral antipsychotics among patients with schizophrenia: a scoping review. BMJ Open 2023; 13:e071984. doi: 10.1136/bmjopen-2023-071984

Young C, MacDougall D. An Overview of Pharmacogenomic Testing for Psychiatric

Disorders. Canadian Journal of Health Technologies, June 2023; Volume 3, Issue 6.